Author:
Alou L.,Anta M.L.,Del Potro M.G.,Fuentes F.,Balcabao I.P.,Gomez-Lus M.L.,Prieto J.
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference20 articles.
1. Analysis of the in vitro activity of trovafloxacin (CP-99,219) against Bacteroides species;Snydman;Infect Dis Clin Pract,1996
2. In vitro activity of the new fluoroquinolone CP-99,219;Neu;Antimicrob Agents Chemother,1984
3. Activity of CP-99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin-tazobactam against 489 anaerobes;Spangler;Antimicrob Agents Chemother,1994
4. Efficacy of trovafloxacin (CP-99,219), a new fluoroquinolone, in an animal model of intraabdominal sepsis;Onderdonk;Infect Dis Clin Pract,1996
5. In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteriodes fragilis and Escherichia coli;Thadepalli;Antimicrob Agents Chemother,1997
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献